Literature DB >> 17684763

Molecular profiles of gastroenteropancreatic endocrine tumors.

Aurel Perren1, Martin Anlauf, Paul Komminoth.   

Abstract

Neuroendocrine tumors of the gastroenteropancreatic system are defined by their endocrine phenotype and share many histopathological and clinical features. However, the fact that the hormone production of tumors depends on their site of origin, that the tumors differ in their biology, and that the association with familial syndromes is nonrandom suggests heterogeneity. It is therefore conceivable that the gastroenteropancreatic neuroendocrine tumors also differ in their molecular profile. This review summarizes and discusses the available data in this field.

Entities:  

Mesh:

Year:  2007        PMID: 17684763     DOI: 10.1007/s00428-007-0449-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  59 in total

1.  Novel candidate tumour suppressor gene loci on chromosomes 11q23-24 and 22q13 involved in human insulinoma tumourigenesis.

Authors:  Y M H Jonkers; S M H Claessen; T Feuth; A Geurts van Kessel; F C S Ramaekers; J A Veltman; E-J M Speel
Journal:  J Pathol       Date:  2006-12       Impact factor: 7.996

2.  Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor.

Authors:  M Fujimori; S Ikeda; Y Shimizu; M Okajima; T Asahara
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

3.  Carcinoid tumors frequently display genetic abnormalities involving chromosome 11.

Authors:  O Jakobovitz; D Nass; L DeMarco; A J Barbosa; F B Simoni; G Rechavi; E Friedman
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

4.  Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors.

Authors:  A Barghorn; E J Speel; B Farspour; P Saremaslani; S Schmid; A Perren; J Roth; P U Heitz; P Komminoth
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

5.  BRAF gene mutations are rare events in gastroenteropancreatic neuroendocrine tumors.

Authors:  Andrea Tannapfel; Susanne Vomschloss; Dorothee Karhoff; Anett Markwarth; Ulrich R Hengge; Christian Wittekind; Rudolf Arnold; Dieter Hörsch
Journal:  Am J Clin Pathol       Date:  2005-02       Impact factor: 2.493

6.  Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors.

Authors:  D Bartsch; S A Hahn; K D Danichevski; A Ramaswamy; D Bastian; H Galehdari; P Barth; W Schmiegel; B Simon; M Rothmund
Journal:  Oncogene       Date:  1999-04-08       Impact factor: 9.867

7.  The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors.

Authors:  N Younes; N Fulton; R Tanaka; J Wayne; F H Straus; E L Kaplan
Journal:  Cancer       Date:  1997-05-01       Impact factor: 6.860

8.  Molecular parameters associated with insulinoma progression: chromosomal instability versus p53 and CK19 status.

Authors:  Y M H Jonkers; S M H Claessen; J A Veltman; A Geurts van Kessel; W N M Dinjens; B Skogseid; F C S Ramaekers; E-J M Speel
Journal:  Cytogenet Genome Res       Date:  2006       Impact factor: 1.636

9.  Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms.

Authors:  B Görtz; J Roth; A Krähenmann; R R de Krijger; S Muletta-Feurer; K Rütimann; P Saremaslani; E J Speel; P U Heitz; P Komminoth
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

10.  Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.

Authors:  E H Wang; S A Ebrahimi; A Y Wu; C Kashefi; E Passaro; M P Sawicki
Journal:  Cancer Res       Date:  1998-10-01       Impact factor: 12.701

View more
  2 in total

Review 1.  Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.

Authors:  Günter Klöppel; Guido Rindi; Martin Anlauf; Aurel Perren; Paul Komminoth
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

2.  The ENETS/WHO grading system for neuroendocrine neoplasms of the gastroenteropancreatic system: a review of the current state, limitations and proposals for modifications.

Authors:  Marcela S Cavalcanti; Mithat Gönen; David S Klimstra
Journal:  Int J Endocr Oncol       Date:  2016-07-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.